Text Size

Conjunctival inflammatory gene expression profiling in dry eye disease: Correlations with HLA-DRA and HLA-DRB1

Kessal K., Liang H., Rabut G., Daull P., Garrigue J.-S., Docquier M., Parsadaniantz S.M., Baudouin C., Brignole-Baudouin F.

  • 2018
  • Frontiers in Immunology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology


  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Sorbonne Université, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France; Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, Paris, France; Quinze-Vingts National Ophthalmology Hospital, DHU Sight Restore, INSERM-DGOS CIC 1423, Paris, France; Santen SAS, Evry, France; IGE3 Genomics Platform University of Geneva, Geneva, Switzerland; Department of Ophthalmology, Ambroise Paré Hospital, APHP, University of Versailles Saint-Quentin en Yvelines, Boulogne-Billancourt, France; Sorbonne Paris Cité Université Paris Descartes, Faculté de Pharmacie de Paris, Paris, France

Related Publications

Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis

Leonardi A., Daull P., Garrigue J.-S., Cavarzeran F., Docquier M., Di Stefano A., Tarricone E., Brun P.

Development of a highly sensitive and reliable enzyme-linked immunosorbent assay for MUC5AC in human tears extracted from schirmer strips

Miyake H., Mori N., Mano H., Imanaka T., Nakamura M.

Correlation between the inflammatory marker HLA-DR and signs and symptoms in moderate to severe dry eye disease

Brignole-Baudouin F., Riancho L., Ismail D., Deniaud M., Amrane M., Baudouin C.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022